RIGEL PHARMACEUTICALS INC (RIGL) Stock Analyst Earnings Estimates
NASDAQ:RIGL - Nasdaq - US7665597024 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 149.2M 37.38% | 120.2M -19.44% | 116.882M -2.76% | 175.23M 49.92% | 202.83M 15.75% | 232.69M 14.72% | 254.54M 9.39% | 281.53M 10.60% | 311.25M 10.56% | 341.51M 9.72% | 365.67M 7.07% | 396.98M 8.56% | |
| EBITDA YoY % growth | -7.84M 72.29% | -53.3M -579.85% | -19.253M 63.88% | 17.334M 190.03% | 33.809M 95.04% | 61.39M 81.58% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9M 68.97% | -54.3M -503.33% | -20.491M 62.26% | 12.628M 161.63% | 25.279M 100.18% | 40.695M 60.98% | 50.225M 23.42% | 50.212M -0.03% | 63.56M 26.58% | 85.985M 35.28% | 50.49M -41.28% | 81.498M 61.41% | |
| Operating Margin | -6.03% | -45.17% | -17.53% | 7.21% | 12.46% | 17.49% | 19.73% | 17.84% | 20.42% | 25.18% | 13.81% | 20.53% | |
| EPS YoY % growth | -1.10 31.25% | -3.40 -209.09% | -1.50 55.88% | 0.40 126.45% | 1.14 187.62% | 1.91 67.08% | 1.92 0.57% | 1.49 -22.07% | 1.83 22.53% | 2.72 48.75% | 2.20 -19.10% | 2.81 27.31% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.37 | 0.18 136.72% | 0.27 550.50% | 0.20 -70.86% | 0.29 -23.29% |
| Revenue Q2Q % growth | 51.1M 42.77% | 45.589M 54.36% | 49.057M 33.16% | 51.78M -6.38% | 55.876M 9.35% |
| EBITDA Q2Q % growth | 9.008M 181.15% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 5.225M 165.77% | 3.925M 156.35% | 5.642M 1,162.19% | 4.907M -65.09% | 6.918M 32.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.70 333.33% | 0.06 | 0.64 | 1,076.54% |
| Q2 2024 Q2Q % growth | -0.06 85.00% | -0.30 | 0.24 | 79.85% |
| Q1 2024 Q2Q % growth | -0.50 37.50% | -0.29 | -0.21 | -70.03% |
| Q4 2023 Q2Q % growth | 0.00 -100.00% | -0.31 | 0.31 | 100.00% |
| Q3 2023 Q2Q % growth | -0.30 72.73% | -0.72 | 0.42 | 58.57% |
| Q2 2023 Q2Q % growth | -0.40 50.00% | -0.80 | 0.40 | 49.72% |
| Q1 2023 Q2Q % growth | -0.80 50.00% | -0.99 | 0.19 | 19.56% |
| Q4 2022 Q2Q % growth | 0.10 107.69% | -1.14 | 1.24 | 108.74% |
| Q3 2022 Q2Q % growth | -1.10 8.33% | -1.37 | 0.27 | 19.78% |
| Q2 2022 Q2Q % growth | -0.80 | -1.25 | 0.45 | 36.08% |
| Q1 2022 Q2Q % growth | -1.60 -172.73% | -1.40 | -0.20 | -14.26% |
| Q4 2021 Q2Q % growth | -1.30 -18.18% | -1.30 | 0.00 | 0.17% |
| Q3 2021 Q2Q % growth | -1.20 -50.00% | -1.02 | -0.18 | -18.04% |
| Q2 2021 Q2Q % growth | -0.80 20.00% | -1.17 | 0.37 | 31.40% |
| Q1 2021 Q2Q % growth | 2.20 69.23% | 0.05 | 2.15 | 4,365.55% |
| Q4 2020 Q2Q % growth | -1.10 -10.00% | -1.16 | 0.06 | 5.13% |
| Q3 2020 Q2Q % growth | -0.80 -14.29% | -1.24 | 0.44 | 35.56% |
| Q2 2020 Q2Q % growth | -1.00 16.67% | -1.36 | 0.36 | 26.52% |
| Q1 2020 Q2Q % growth | 1.30 218.18% | 1.34 | -0.04 | -3.13% |
| Q4 2019 Q2Q % growth | -1.00 | -0.83 | -0.17 | -20.83% |
| Q3 2019 Q2Q % growth | -0.70 | -1.12 | 0.42 | 37.69% |
| Q2 2019 Q2Q % growth | -1.20 | -1.39 | 0.19 | 13.49% |
| Q1 2019 Q2Q % growth | -1.10 | -1.36 | 0.26 | 18.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 55.307M 96.58% | 42.766M | 12.541M | 29.32% |
| Q2 2024 Q2Q % growth | 36.841M 37.03% | 34.088M | 2.753M | 8.08% |
| Q1 2024 Q2Q % growth | 29.534M 13.29% | 31.91M | -2.376M | -7.45% |
| Q4 2023 Q2Q % growth | 35.792M -30.20% | 34.784M | 1.008M | 2.90% |
| Q3 2023 Q2Q % growth | 28.134M 25.54% | 27.745M | 389K | 1.40% |
| Q2 2023 Q2Q % growth | 26.886M -9.84% | 26.218M | 668K | 2.55% |
| Q1 2023 Q2Q % growth | 26.07M 55.73% | 24.554M | 1.516M | 6.17% |
| Q4 2022 Q2Q % growth | 51.28M 151.25% | 28.527M | 22.753M | 79.76% |
| Q3 2022 Q2Q % growth | 22.41M 4.04% | 23.062M | -652K | -2.83% |
| Q2 2022 Q2Q % growth | 29.82M 13.51% | 24.128M | 5.692M | 23.59% |
| Q1 2022 Q2Q % growth | 16.74M -79.34% | 17.895M | -1.155M | -6.45% |
| Q4 2021 Q2Q % growth | 20.41M 10.62% | 22.337M | -1.927M | -8.63% |
| Q3 2021 Q2Q % growth | 21.54M 17.13% | 24.033M | -2.493M | -10.37% |
| Q2 2021 Q2Q % growth | 26.27M 63.98% | 20.777M | 5.493M | 26.44% |
| Q1 2021 Q2Q % growth | 81.02M 45.30% | 31.672M | 49.348M | 155.81% |
| Q4 2020 Q2Q % growth | 18.45M 19.81% | 18.463M | -13K | -0.07% |
| Q3 2020 Q2Q % growth | 18.39M -11.84% | 17.58M | 810K | 4.61% |
| Q2 2020 Q2Q % growth | 16.02M 53.89% | 14.024M | 1.996M | 14.23% |
| Q1 2020 Q2Q % growth | 55.76M 341.84% | 57.841M | -2.081M | -3.60% |
| Q4 2019 Q2Q % growth | 15.4M | 15.969M | -569K | -3.56% |
| Q3 2019 Q2Q % growth | 20.86M | 16.708M | 4.152M | 24.85% |
| Q2 2019 Q2Q % growth | 10.41M | 9.467M | 943K | 9.96% |
| Q1 2019 Q2Q % growth | 12.62M | 11.602M | 1.018M | 8.77% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 22% | 95.53% | 35.38% | 211.25% |
| Revenue | 5.64% | 5.03% | 1.59% | 9.46% |